Kushner Joshua 的 Form 4 申報

Oscar Health, Inc.（OSCR），2026/9/18 申報

申報編號: 0001193125-26-395853
申報時間: 2026/9/18 20:27 ET
交易日: 2026/9/18
申報延遲: 當天
10b5-1 計畫: 沒有勾選

SEC EDGAR 原文（在新分頁開啟）

這份申報列了 8 筆非衍生性交易、5 筆衍生性交易。交易當天就申報。

申報人

一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人	與公司的關係
Kushner JoshuaCIK 0001844181	董事、高階主管（共同創辦人、副董事長）、持股 10% 以上大股東

非衍生性證券（表 I）

普通股等股票的取得與處分，每一列是申報上的一筆。

非衍生性證券的交易
交易日	證券	交易	股數	價格	金額	交易後持股	持有方式	旗標
2026/9/18	Class A Common Stock	J其他處分	−6,268,097	$0.00^F1	$0	0	間接	重複申報
2026/9/18	Class A Common Stock	J其他處分	−75,520	$0.00^F1	$0	0	間接	重複申報
2026/9/18	Class A Common Stock	J其他取得	+1,323,589	$0.00^F1	$0	1,323,589	間接	重複申報
2026/9/18	Class A Common Stock	J其他取得	+4,855,810	$0.00^F1	$0	4,855,810	間接	重複申報
2026/9/18	Class A Common Stock	J其他取得	+164,218	$0.00^F1	$0	164,218	間接	重複申報
2026/9/18	Class A Common Stock	J其他處分	−1,323,589	$0.00^F4	$0	0	間接	重複申報
2026/9/18	Class A Common Stock	J其他處分	−4,855,810	$0.00^F4	$0	0	間接	重複申報
2026/9/18	Class A Common Stock	J其他處分	−164,218	$0.00^F4	$0	0	間接	重複申報

衍生性證券（表 II）

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日	證券	交易	標的股數	單價	金額	交易後持有	持有方式	旗標
2026/9/18	Class A Common Stock	J其他處分	−1,323,589	$0.00^F1	$0	4,779,730	間接	重複申報
2026/9/18	Class A Common Stock	J其他處分	−4,855,810	$0.00^F1	$0	17,535,258	間接	重複申報
2026/9/18	Class A Common Stock	J其他處分	−164,218	$0.00^F1	$0	593,021	間接	重複申報
2026/9/18	Class A Common Stock	J其他取得	+6,268,097	$0.00^F1	$0	6,268,097	間接	重複申報
2026/9/18	Class A Common Stock	J其他取得	+75,520	$0.00^F1	$0	75,520	間接	重複申報

附註與備註

本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。

On September 18, 2026, (i) Thrive Capital Partners II, L.P. ("Thrive II") transferred 1,307,831 and 15,758 shares of Class B Common Stock to Thrive Capital Partners VII Growth, L.P. ("Thrive VII Growth") and Claremount VII Associates, L.P. ("Claremount VII"), respectively, in exchange for 1,307,831 and 15,758 shares of Class A Common Stock held by Thrive VII Growth and Claremount VII, respectively; (ii) Thrive Capital Partners III, L.P. ("Thrive III") transferred 4,798,003 and 57,807 shares of Class B Common Stock to Thrive VII Growth and Claremount VII, respectively, in exchange for 4,798,003 and 57,807 shares of Class A Common Stock held by Thrive VII Growth and Claremount VII, respectively; (iii) Claremount TW, L.P. ("Claremount TW") transferred 162,263 and 1,955 shares of Class B Common Stock to Thrive VII Growth and Claremount VII, respectively, in exchange for 162,263 and 1,955 shares of Class A Common Stock held by Thrive VII Growth and Claremount VII, respectively.

表 I 有 5 筆、表 II 有 5 筆交易的價格引用這則附註。

On September 18, 2026, (i) Thrive II distributed to its limited partners and sole general partner, pro rata and without consideration, 1,323,589 shares of Class A Common Stock; (ii) Thrive III distributed to its limited partners and sole general partner, pro rata and without consideration, 4,855,810 shares of Class A Common Stock; and (iii) Claremount TW distributed to its limited partners and sole general partner, pro rata and without consideration, 164,218 shares of Class A Common Stock. Each of Thrive Partners II GP, LLC and Thrive Partners III GP, LLC, in turn, distributed to their members, pro rata and without consideration, the shares of Class A Common Stock received in the foregoing distributions. Such distributions were made in accordance with the exemptions afforded by Rule 16a-9(a) and Rule 16a-13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

表 I 有 3 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文（在新分頁開啟）